Stock GMAB GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Valuation Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen
Other stock markets
 08:50:00 17/09/2024 pm IST 		5-day change 1st Jan Change
1,775.00 DKK -0.08% Intraday chart for Genmab A/S -4.29% -17.63%
16/09 Genmab Reports 'Encouraging' Data From Phase 1/2 Study of Investigational Ovarian Cancer Drug MT
16/09 Genmab Reports 'Encouraging Response Rate' from Investigational Ovarian Cancer Treatment Trial MT

Company Valuation: Genmab A/S

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 96,408 1,61,105 1,72,063 1,92,229 1,40,770 1,12,723 - -
Change - 67.11% 6.8% 11.72% -26.77% -19.92% - -
Enterprise Value (EV) 1 85,618 1,45,026 1,52,725 1,69,905 1,12,635 88,465 83,240 75,090
Change - 69.39% 5.31% 11.25% -33.71% -21.46% -5.91% -9.79%
P/E ratio 43.5x 34.1x 57.8x 35.2x 32.6x 21.5x 18.9x 14.8x
PBR 6.85x 8.5x 7.82x 7.07x 4.5x 3.4x 2.85x 2.36x
PEG - 0x -1.6x 0.4x -1.5x 0.9x 1.3x 0.5x
Capitalization / Revenue 18x 15.9x 20.3x 13.2x 8.54x 5.4x 4.59x 3.91x
EV / Revenue 16x 14.3x 18x 11.6x 6.84x 4.24x 3.39x 2.6x
EV / EBITDA 30.8x 22.1x 46.8x 25.3x 20.1x 13.9x 10.2x 7.26x
EV / EBIT 32.5x 23x 50.6x 26.7x 21.2x 14.6x 10.7x 7.46x
EV / FCF 68.7x 23.7x 77.3x 47.3x 16.1x 30.5x 13.1x 9.43x
FCF Yield 1.46% 4.22% 1.29% 2.12% 6.23% 3.28% 7.64% 10.6%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 34.03 72.21 45.54 83.65 66.02 82.51 94.09 120.2
Distribution rate - - - - - - - -
Net sales 1 5,366 10,111 8,482 14,595 16,474 20,874 24,585 28,860
EBITDA 1 2,777 6,572 3,266 6,719 5,616 6,375 8,174 10,348
EBIT 1 2,638 6,313 3,018 6,357 5,321 6,072 7,748 10,060
Net income 1 2,166 4,758 3,008 5,522 4,352 5,406 6,318 8,078
Net Debt 1 -10,790 -16,079 -19,338 -22,324 -28,135 -24,258 -29,483 -37,633
Reference price 2 1,481.50 2,463.00 2,630.00 2,941.00 2,155.00 1,775.00 1,775.00 1,775.00
Nbr of stocks (in thousands) 65,075 65,410 65,423 65,362 65,322 63,506 - -
Announcement Date 19/02/20 23/02/21 16/02/22 22/02/23 14/02/24 - - -
1DKK in Million2DKK
Estimates

P/E ratio, Detailed evolution

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
GENMAB A/S Stock Genmab A/S
21.53x4.24x13.89x-.--%16.82B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-246.97x10.83x142.55x-.--%126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
30.95x8.14x19.84x-.--%124B
ARGENX SE Stock argenx SE
-527.02x14.5x-176.06x-.--%32.29B
BIONTECH SE Stock BioNTech SE
-46.31x5.15x-14.58x-.--%29.36B
BEIGENE, LTD. Stock BeiGene, Ltd.
-32.26x5.3x-32.57x-.--%20.89B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
12.13x2.65x7.52x+2.42%16.04B
VAXCYTE, INC. Stock Vaxcyte, Inc.
-25.49x - - -.--%14.13B
INSMED INCORPORATED Stock Insmed Incorporated
-14.09x36.79x-17.16x-.--%12.58B
Average -91.95x 10.95x -7.07x +0.27% 43.65B
Weighted average by Cap. -118.05x 9.74x 36.49x +0.10%
See all sector valuations

Income Statement and Estimates

More financial data

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Valuation Genmab A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition